Antimuscarinic agents in elderly people. - Wikidata - awgldk - TriplyDB

Antimuscarinic agents in elderly people.

Antimuscarinic agents in elderly people.

http://www.wikidata.org/entity/Q51037347

about

Antimuscarinic agents in elderly people.

http://www.wikidata.org/entity/Q51037347

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Antimuscarinic agents in elderly people.

@en

Antimuscarinic agents in elderly people.

@nl

type

label

Antimuscarinic agents in elderly people.

@en

Antimuscarinic agents in elderly people.

@nl

prefLabel

Antimuscarinic agents in elderly people.

@en

Antimuscarinic agents in elderly people.

@nl

P1433

Q51037347-64BC97C8-A968-4C2A-B4E6-457E50FAA985

P1476

Q51037347-6F7FBD5D-BF13-4323-BB1D-48A0C923FB97

P2093

Q51037347-9ED62AAB-1BBE-4E3E-A291-4C1679676D43

P2860

Q51037347-005EAF95-DFCE-44AA-A74A-272161249938

Q51037347-02F1EA45-A58C-488C-A8C3-6126FB0F154E

Q51037347-0F29D756-B504-451A-BE0C-A05D92683E94

Q51037347-357364DB-92AF-47C2-8550-91A0327F074A

Q51037347-402F366F-FD05-4BEA-B73C-0FDCE21A1639

Q51037347-5763E713-C0A8-4284-9177-49535CC1B0AB

Q51037347-68714E64-4D3B-450D-B9BB-06B513736334

Q51037347-6B09A6C9-6A91-4CAF-AA1C-0416B897E907

Q51037347-93A28DFE-D1D6-4859-BAF3-C38A0DD9D0F2

Q51037347-D932E16D-F30D-4364-94F8-F407276B1C47

P304

Q51037347-47ECA53E-0DB1-49B7-9D99-8CCF51EBE263

P31

Q51037347-65e41831-8835-45d5-920e-0bebfcde6067

Q51037347-E599054E-02CA-4F7A-8946-05DDDEC61145

P356

Q51037347-199A419F-49BE-447D-8EEB-2D0503685146

P433

Q51037347-A0A47747-0B81-4624-BF5A-D20A8AB61668

P478

Q51037347-0EC12FE9-B6A0-4F05-B218-36B2C58AF6D1

P50

Q51037347-468A6927-2931-4F46-943C-D1700C2AE331

P577

Q51037347-FAE49F1C-0EF3-422C-81F1-A01DF6969360

P698

Q51037347-5F200E52-55B9-4295-B8A4-FC3DEE5E8C6A

P356

J.1742-1241.2010.02504.X

P1433

International Journal of Clinical Practice

P1476

Antimuscarinic agents in elderly people.

@en

P2093

A Mangera

http://www.w3.org/2001/XMLSchema#string

P2860

Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder

Overactive bladder syndrome in older people.

Physiological and pathological regulation of the autonomic control of urinary bladder contractility.

Preserving cognitive function for patients with overactive bladder: evidence for a differential effect with darifenacin.

Listening to the patient: a flexible approach to the use of antimuscarinic agents in overactive bladder syndrome.

[How do medications used to treat urinary incontinence affect the cerebral function of the elderly?]

Do gender, age or lifestyle factors affect responses to antimuscarinic treatment in overactive bladder patients?

Trospium chloride once-daily extended release is effective and well tolerated for the treatment of overactive bladder syndrome: an integrated analysis of two randomised, phase III trials.

Effects on sleep of anticholinergics used for overactive bladder treatment in healthy volunteers aged > or = 50 years.

Cardiovascular safety and overall tolerability of solifenacin in routine clinical use: a 12-week, open-label, post-marketing surveillance study.

P304

1467-1468

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1742-1241.2010.02504.X

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P50

Christopher R Chapple

P577

2010-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20846192

http://www.w3.org/2001/XMLSchema#string